Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q4 EPS of ($1.13), versus $1.31 reported last year. Revenue for the quarter came in at $105 thousand, versus $214 thousand reported last year.

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.